Signaling of
transforming growth factor β (TGF-β) is redirected in
cancer to promote
malignancy, but how TGF-β function is altered in a transformed cell is not fully understood. We investigated TGF-β signaling by profiling
proteins that differentially bound to type I TGF-β receptor (TβRI) in nontransformed, HER2-transformed, and HER2-negative
breast cancer cells using immunoprecipitation followed by
protein identification. Interestingly, several
nuclear proteins implicated in posttranscriptional RNA processing were uniquely identified in the TβRI coprecipitates from HER2-transformed cells.
Ligand-inducible nuclear translocation of TβRI was observed only in transformed cells, and the translocation required
importin β1,
nucleolin, and Smad2/3. This trafficking was dependent on the high Ran
GTPase activity resulting from oncogenic transformation. In the nucleus, TβRI associated with
purine-rich RNA sequences in a synergistic manner with the
RNA-binding factor
hnRNP A1. We further found that nuclear translocation of TβRI specifically induced
epidermal growth factor receptor (EGFR) transcript
isoform c, which encodes a soluble EGFR
protein, through alternative splicing or 3'-end processing. Our study confirms a
cancer-specific nuclear translocation of TβRI and demonstrates its potential function in regulating
nuclear RNA processing, as well as a novel gain-of-function mechanism of TGF-β signaling in
cancer.